537 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Purchased by Vision Capital Management Inc.

Vision Capital Management Inc. purchased a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 537 shares of the healthcare conglomerate's stock, valued at approximately $272,000.

Other hedge funds have also added to or reduced their stakes in the company. M&T Bank Corp lifted its position in shares of UnitedHealth Group by 13.4% during the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate's stock worth $128,975,000 after buying an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC boosted its stake in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate's stock valued at $4,025,000 after acquiring an additional 1,193 shares during the last quarter. Benjamin Edwards Inc. raised its holdings in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate's stock worth $26,060,000 after purchasing an additional 41,308 shares during the period. Parsifal Capital Management LP purchased a new stake in UnitedHealth Group in the third quarter worth $21,165,000. Finally, Signal Advisors Wealth LLC raised its stake in UnitedHealth Group by 13.0% in the 4th quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate's stock valued at $4,611,000 after acquiring an additional 1,051 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.

UnitedHealth Group Trading Down 1.9 %

Shares of NYSE UNH traded down $10.11 during midday trading on Thursday, reaching $529.71. The company had a trading volume of 3,924,803 shares, compared to its average volume of 4,447,235. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm's fifty day moving average price is $532.43 and its 200-day moving average price is $564.77. The stock has a market cap of $487.48 billion, a PE ratio of 34.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts' consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm's revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the business posted $5.83 EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently commented on the stock. Piper Sandler cut their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an "overweight" rating for the company in a report on Thursday, January 2nd. Morgan Stanley reduced their target price on UnitedHealth Group from $615.00 to $610.00 and set an "overweight" rating for the company in a report on Wednesday, October 16th. Wells Fargo & Company reduced their price objective on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Royal Bank of Canada reduced their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating for the company in a research report on Wednesday, October 16th. Finally, Bank of America reduced their target price on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating for the company in a research report on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Corporate insiders own 0.33% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.